Journal of Clinical Medicine (Aug 2019)

Patients with ANCA-Associated Glomerulonephritis and Connective Tissue Diseases: A Comparative Study from the Maine-Anjou AAV Registry

  • Fanny Guibert,
  • Anne-Sophie Garnier,
  • Samuel Wacrenier,
  • Giorgina Piccoli,
  • Assia Djema,
  • Renaud Gansey,
  • Julien Demiselle,
  • Benoit Brilland,
  • Maud Cousin,
  • Virginie Besson,
  • Agnès Duveau,
  • Khuzama El Nasser,
  • Jean-Philippe Coindre,
  • Anne Croue,
  • Jean-Paul Saint-André,
  • Alain Chevailler,
  • Jean-François Subra,
  • Jean-François Augusto

DOI
https://doi.org/10.3390/jcm8081218
Journal volume & issue
Vol. 8, no. 8
p. 1218

Abstract

Read online

Background and objectives: The overlap between antineutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis (ANCA-GN) and connective tissue diseases (CTD) has been reported mainly as case series in the literature. Frequency of this association, as well as presentation and outcomes are unknown. Materials and Methods: Patients from the Maine-Anjou ANCA-associated vasculitides (AAV) registry with ANCA-GN diagnosed between 01/01/2000 and 01/01/2018, ANCA positivity, and at least six months of follow-up, were included. Results: 106 out of 142 patients fulfilled the inclusion criteria and were analyzed. CTD was present at ANCA-GN diagnosis in 16 (15.1%) patients. The most common CTD were rheumatoid arthritis, Sjogren syndrome and systemic sclerosis. Compared to the control group, females were more represented in the CTD group (75%, p = 0.001). Renal presentation was comparable between groups, including the pathological analysis of renal biopsies. Patients of CTD group presented a higher rate of non-renal relapse (25% versus 7.7%, p = 0.037), and experienced more frequently a venous thrombotic event (31.2% versus 10%, p = 0.021). No difference between groups was observed according to major outcomes. Conclusion: Association between CTD and ANCA-GN is not a rare condition and predominantly affects females. While AAV presentation is not significantly different, CTD patients experience more frequently non-renal relapse and venous thrombotic events.

Keywords